These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20686748)

  • 1. Intensified glucose lowering in type 2 diabetes: time for a reappraisal.
    Yudkin JS; Richter B; Gale EA
    Diabetologia; 2010 Oct; 53(10):2079-85. PubMed ID: 20686748
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensified glucose lowering in type 2 diabetes: time for a bolder reappraisal.
    Czupryniak L; Szymańska-Garbacz E; Pawłowski M; Saryusz-Wolska M; Loba J
    Diabetologia; 2011 Mar; 54(3):701-2; author reply 707-8. PubMed ID: 21161162
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensified glucose lowering in type 2 diabetes: don't throw the baby out with the bathwater.
    DeVries JH
    Diabetologia; 2011 Mar; 54(3):705-6; author reply 707-8. PubMed ID: 21127831
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association.
    Diabetes Care; 1995 Nov; 18(11):1510-8. PubMed ID: 8722084
    [No Abstract]   [Full Text] [Related]  

  • 5. Intervention at the very early stage of type 2 diabetes.
    Aizawa T; Funase Y
    Diabetologia; 2011 Mar; 54(3):703-4; author reply 707-8. PubMed ID: 21127829
    [No Abstract]   [Full Text] [Related]  

  • 6. Extent of glycemic control in type 2 diabetes mellitus: close, but no cigar.
    Lerch C; Richter B
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):593-5. PubMed ID: 19833492
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review.
    Jørgensen ME; Faurholt-Jepsen D
    Curr Diab Rep; 2014 Jul; 14(7):505. PubMed ID: 24806518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes - controlling hyperglycaemia with early insulin use.
    MacIsaac R; Cheung A; Jerums G
    Aust Fam Physician; 2010 Aug; 39(8):565-9. PubMed ID: 20877750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hyperglycemia.
    Flansbaum B
    J Hosp Med; 2006 Nov; 1(6):382; author reply 382-5. PubMed ID: 17219535
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
    Lebovitz HE
    Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current, new, and emerging therapies for managing hyperglycaemia in type 2 diabetes.
    Munro N; Feher MD
    Br J Gen Pract; 2008 Aug; 58(553):531-3. PubMed ID: 18682016
    [No Abstract]   [Full Text] [Related]  

  • 12. [The current aspects of the pharmacological correction of hyperglycemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
    Gorbenko NI
    Eksp Klin Farmakol; 1999; 62(5):71-8. PubMed ID: 10572759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus in the next decade: novel pipeline medications to treat hyperglycemia.
    Fonseca V
    Clin Ther; 2013 May; 35(5):714-23. PubMed ID: 23688536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.
    Mazzone T
    Circulation; 2010 Nov; 122(21):2201-11. PubMed ID: 21098460
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose products.
    Berg EG
    Diabetes Forecast; 2014 Jan; 67(1):76-7. PubMed ID: 25868301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].
    Clodi M; Abrahamian H; Brath H; Brix J; Drexel H; Fasching P; Föger B; Francesconi C; Fröhlich-Reiterer E; Harreiter J; Hofer SE; Hoppichler F; Huber J; Kaser S; Kautzky-Willer A; Lechleitner M; Ludvik B; Luger A; Mader JK; Paulweber B; Pieber T; Prager R; Rami-Merhar B; Resl M; Riedl M; Roden M; Saely CH; Schelkshorn C; Schernthaner G; Sourij H; Stechemesser L; Stingl H; Toplak H; Wascher TC; Weitgasser R; Winhofer-Stöckl Y; Zlamal-Fortunat S
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):27-38. PubMed ID: 30980148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do not forget that type 2 diabetes does not only expose to cardiovascular complications.
    Halimi S
    Diabetes Metab; 2014 Jun; 40(3):167-8. PubMed ID: 24751987
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 19. alpha-Glucosidase inhibitors.
    Lebovitz HE
    Endocrinol Metab Clin North Am; 1997 Sep; 26(3):539-51. PubMed ID: 9314014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.